Unprecedented advances in our understanding of the pathobiology, prognostication, and
therapeutic options in mantle cell lymphoma (MCL) have taken place in the last few years …

Mantle cell lymphoma (MCL) is clinically characterised by its heterogenous behaviour with
courses ranging from indolent cases that do not require therapy for years to highly …

The field of mantle cell lymphoma (MCL) has witnessed remarkable progress due to
relentless advances in molecular pathogenesis, prognostication, and newer treatments …

To investigate the three-dimensional (3D) genome architecture across normal B cell
differentiation and in neoplastic cells from different subtypes of chronic lymphocytic leukemia …

We analyzed the in silico purified DNA methylation signatures of 82 mantle cell lymphomas
(MCL) in comparison with cell subpopulations spanning the entire B cell lineage. We …

Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are 2 well-defined
entities that diverge in their basic pathogenic mechanisms and clinical evolution but they …

Sporadic Burkitt lymphoma (BL) is the most frequent tumour of children and adolescents but
a rare subtype of lymphomas in adults. To date most molecular data have been obtained …

Sex-determining region Y-related high-mobility-group box transcription factor 11 (SOX11) is
an essential member of the SOX transcription factors and has been highlighted as an …

SOX11 is a relevant element in the pathogenesis of MCL and has been instrumental to
identify two distinct clinicobiological subtypes of this tumor. Further studies should clarify the …

CD200, a marker currently utilized in the diagnosis of B-cell lymphoma, is uniformly positive
in chronic lymphocytic leukemia/chronic lymphocytic leukemia, and is usually absent in …